Table:
begin	end	state
1	11	cytoplasmic
12	29	transmembrane
30	40	non-cytoplasmic
41	60	transmembrane
61	92	cytoplasmic
93	117	transmembrane
118	125	non-cytoplasmic
126	145	transmembrane
146	158	cytoplasmic
159	180	transmembrane
181	201	non-cytoplasmic
202	222	transmembrane
223	233	cytoplasmic
234	256	transmembrane
257	280	non-cytoplasmic
281	309	transmembrane
310	330	cytoplasmic
331	352	transmembrane
353	357	non-cytoplasmic
358	382	transmembrane
383	394	cytoplasmic
395	413	transmembrane
414	418	non-cytoplasmic
419	437	transmembrane
438	447	cytoplasmic
448	469	transmembrane
470	475	non-cytoplasmic

Input:
>PfGW456L13_1876
MSQSPNKLRLSALIALVVGSMIGGGIFSLPQNMAARADAGAILIGWAITAVGMLTLAFVF
QTLANRKPELDSGVYAYAKAGFGDYMGFSSAWGYWISAWLGNVGYFVLLFSTLGYFVPVF
GEGNTPIAIACASVLLWTVHFVVMRGIKEAAFINQVTTVAKIVPLIMFIVIAAVAFKADI
FTADIWGRNNPEFGSVMDQVRHMMLVTVFVFIGIEGASVYSARAEKRSDVGRATVIGFIG
VLALLVLVNVLSLGIMTQPQLAKLQNPSLAAVLEHIVGPWGALLISVGLAISLLGALLSW
ALLCAEILFATAKDKTMPAFLTKENANHVPVNAMWLTNSMIQLFLLITLFSAGTYTSLIY
LASSMILVPYLWSAAYAVLLCARGETYQQAPAERIKDLLIGGIALGYAVWLLYAGGLKYL
LLSALLYAPGVILFAKARNEQGKPLFTVVEKGIFTCVIGGAGLAAYGLYSGLLSL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server